Eugene Frederick Leffler III - 22 Jul 2025 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Reporting relationship: Chief Financial Officer
Issuer ticker: BFRI
Reported as of: 22 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Sep 2025, 21:19:41 UTC
Prior SEC filing: 16 Jul 2024
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Daniel Hakansson, Attorney-in-fact for Eugene Frederick Leffler III

Key filing fact

Eugene Frederick Leffler III filed Form 4 for Biofrontera Inc. (BFRI) on 16 Sep 2025.

Key facts

This page summarizes Eugene Frederick Leffler III's Form 4 filing for Biofrontera Inc. (BFRI).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 16 Sep 2025, 21:19.

Change

Previous filing in this sequence was filed on 16 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001952347 Primary reporting owner

Leffler Eugene Frederick

Relationship: Chief Financial Officer
Address: 120 PRESIDENTIAL WAY, SUITE 330, WOBURN
Signature: /s/ Daniel Hakansson, Attorney-in-fact for Eugene Frederick Leffler III
Signature date: 16 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BFRI transaction

Common Stock

Options Exercise

Transaction value
Shares: +87,500
Change %
Price
Shares after: 87,500
Date: 10 Sep 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BFRI transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +62,500
Change %
Price: $0.000000
Shares after: 62,500
Date: 22 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62,500
Exercise price
Footnotes: F2, F3, F6

BFRI transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +62,500
Change %
Price: $0.000000
Shares after: 62,500
Date: 22 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62,500
Exercise price: $1.00
Footnotes: F4, F7

BFRI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -87,500
Change %: -50%
Price: $0.000000
Shares after: 87,500
Date: 10 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 87,500
Exercise price
Footnotes: F1, F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of BFRI common stock. The reporting person received the restricted stock units as an award for no consideration.

Footnote F3

The restricted stock units vest in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

Footnote F4

The option vests in two equal annual installments beginning on January 22, 2026.

Footnote F5

On July 12, 2024 the reporting person was granted 175,000 restricted stock units, vesting in two equal annual installments beginning on July 12, 2025. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

Footnote F6

Restricted stock units with different terms are not included.

Footnote F7

Options with different terms are not included